Quinn
Your biopharma team, from molecule design to portfolio strategy
San Francisco
5 employees
Drug Discovery and Delivery
Seed
About Quinn
Your biopharma team, from molecule design to portfolio strategy
Your biopharma team, from molecule design to portfolio strategy
Your biopharma team, from molecule design to portfolio strategy
Last stage
Seed
Investors
Daniel Gomari
Daniel Gomari is the founder and CEO of Quinn. A Stanford postdoc and PhD in Computational Biology, his work spanned ML for drug repurposing across cancer and metabolic disease, and multi-omics studies on aging and lifespan extension. He built Quinn after watching the pharma industry make billion-dollar R&D decisions on intuition and slide decks instead of computational evidence.
LinkedInMike Snyder
Professor of Genetics at Stanford University with 900+ publications. Co-founded Quinn (developed under parent company iollo) alongside Daniel Gomari.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.